David Black, MD
Gastroenterology · Whiteland, INNPI 1841400371
Payments from drug & device makers
Across 664 payments — averaging $18.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Johnson & Johnson$2K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$921
- Pfizer$880
- Bristol Myers Squibb$573
- plus $3K from 24 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 157 | $3,329 |
| Johnson & Johnson(3 entities) | 76 | $1,543 |
| Takeda Pharmaceuticals U.S.A., Inc. | 138 | $1,494 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 64 | $921 |
| Pfizer | 57 | $880 |
| Bristol Myers Squibb | 31 | $573 |
| Gilead | 26 | $546 |
| Sanofi | 18 | $328 |
| Lilly USA, LLC | 16 | $282 |
| Ironwood Pharmaceuticals, Inc | 12 | $250 |
| Phathom Pharmaceuticals, Inc. | 9 | $243 |
| E.r. Squibb & Sons, L.L.C. | 2 | $215 |
| Regeneron Healthcare Solutions, Inc. | 8 | $211 |
| Madrigal Pharmaceuticals | 10 | $152 |
| Novo Nordisk | 5 | $148 |
| Braintree Laboratories, Inc. | 4 | $135 |
| Redhill Biopharma Inc. | 3 | $132 |
| Ferring Pharmaceuticals Inc. | 7 | $108 |
| QOL Medical, LLC | 6 | $107 |
| Janssen Scientific Affairs, LLC | 1 | $88 |
| Ardelyx, Inc. | 3 | $80 |
| Ipsen Biopharmaceuticals, Inc | 3 | $63 |
| Organon | 1 | $38 |
| Celltrion USA Inc. | 1 | $21 |
| Echosens North America, Inc. | 1 | $19 |
| UCB, Inc. | 1 | $19 |
| Alfasigma USA, Inc. | 1 | $17 |
| Biocon Biologics Inc | 1 | $16 |
| Intercept Pharmaceuticals, Inc. | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $12 |
How this compares
$11,986 in reported general payments places this provider in the 80th percentile of 323 gastroenterology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Whiteland
- Monika FischerIndianapolis$2.8M
- Douglas RexIndianapolis$2.3M
- Pankaj PatelSouth Bend$2.3M
- David PoundIndianapolis$1.4M
- Naga ChalasaniIndianapolis$1.1M
- Sashidhar SagiWestfield$1.1M
- Jonathan ObertNew Albany$758K
- David DresnerNew Albany$544K
- Marwan GhabrilIndianapolis$464K
- Matthew BohmWestfield$437K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.